Zenas BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	329	342	-	-
Enterprise Value	-8	-44	-	-
Last Close Price	8.17	8.19	-	-
Debt / Equity Ratio	0.00	0.00	0.87	0.03
Asset Turnover	0.02	0.02	0.70	-
Quick Ratio	6.12	6.12	2.44	2.59
Current Ratio	6.21	6.21	2.57	2.64
Return on Equity (ROE)	-93.22%	-93.22%	-102.89%	-
Return on Assets (ROA)	-46.76%	-46.76%	-23.77%	-
Return on Capital (ROIC)	-57.07%	-57.07%	-35.79%	-
Buyback Yield / Dilution	-762.01%	-762.01%	-2.61%	-

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q